Navigation Links
Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments

of life than patients taking triptans, according to the survey. Patients taking these drugs were twice as likely as patients on triptans to say that migraines "always" limited their ability to exercise or play sports (35% vs. 14%), engage in sexual activity (33% vs. 17%), drive a car (28% vs. 14%), spend time with family and friends (28% vs. 8%) or simply get out of the house (33% vs. 15%).

Addiction can lead to hospitalization

Cathy Turley, of Rye Brook, NY, who was not involved in the survey, said that in the process of trying to relieve her "debilitating" migraines, which caused her to miss two to three days of work a week, she had become addicted to a medication that contained a barbiturate.

"I was up to 10 or 12 of those [pills] a day," Turley said. "I would take as many as I could as long as I had the headache. That was why I got up to so many pills. It was absolutely the wrong medication for me to take, because it was making the migraine worse."

After spending five days in the hospital to get weaned off the barbiturate, Turley was prescribed a medication specifically approved to treat migraines. The medication has "given me back my life," she said.

Physicians say that detoxification from barbiturate and opioid over-use in headache patients may require hospitalization. (1)

Migraine Patients Want FDA-Approved, Non-Addictive Treatments

Though many patients are prescribed barbiturates and opioids for their migraines, the majority indicated that they prefer their migraine medication to be FDA approved for the disease, not addictive and have few side effects. Seven out of ten patients (72%) surveyed said it's "extremely" or "very" important that their prescription medications not be addictive, and eight out of ten patients (79%) said it's "extremely" or "very" important that their prescription medication have only minor side effects. Sixty-five percent said it's important that their migraine medication be approved b
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
3. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
6. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
7. Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
8. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/4/2015)... , Sept. 4, 2015 Physician E-sampling is ... and has become a key marketing sales tactic in ... fully adopt E-sampling as a supplement to traditional sampling. ... Best Practices, LLC, physician E-sampling has been seeded across ... chronic areas. While E-sampling has been in place for ...
(Date:9/4/2015)... -- Janssen Research & Development, LLC (Janssen) announced today ... accepted for Priority Review the Biologics License Application ... with multiple myeloma who are refractory to both ... (IMiD), or who have received three or more ... an IMiD. This is referred to as "double ...
(Date:9/4/2015)... Fair Rate Funding, a lawsuit funding firm located in ... in lawsuit filings in connection with the blood thinning drug, ... Philadelphia Court of Common Pleas has risen ... Louisiana multi---district litigation (MDL), located in the ... Louisiana , the filings are also on the rise, ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... April 9, 2008 Dutch biotechnology,company Crucell N.V., ... South,African Tuberculosis Vaccine Initiative (SATVI) present a progress ... tuberculosis vaccine study at the,biennial "Tuberculosis Vaccines for ... today. The study, conducted in Worcester, South,Africa and ...
... NEW YORK, April 9, 2008 Intra-Cellular ... its ongoing development,programs for ITI-007, the Company,s ... (DPPM), and ITI-722,a low-dose formulation of ITI-007, ... disorders, respectively. These new data demonstrate,ITI-007 has ...
Cached Medicine Technology:Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3
(Date:9/4/2015)... San Diego, California (PRWEB) , ... September 04, 2015 , ... ... affiliates on behalf of Tanya De La Paz. , Schmidt National Law Group, ... for the Northern District of California against Bayer Corp., Bayer Essure, Inc., and other ...
(Date:9/4/2015)... ... September 04, 2015 , ... After wearing the same uniforms ... of new apparel. In an effort to assist the team, the Jones Agency, a ... charity drive to raise funds for the new uniforms. , As is so often ...
(Date:9/4/2015)... Valley Forge, PA (PRWEB) , ... September 04, 2015 , ... ... mold growth in and around the home is quite common. Mold can grow anywhere ... as areas around leaking pipes. Checking for excessive moisture and water in the home ...
(Date:9/4/2015)... PA (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for a ... could be their solution. , The patent-pending K Med Cups provide a quick and simple ... help to relieve a cold, flu or cough. As a result, they enhance comfort and ...
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety ... visits which affects hospitals’ abilities to provide quality service to those with serious needs, ... this problem has recently presented itself, the new telemedicine platform and app, DocChat ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3
... ... PTCA Catheters is Compact, Easy to Operate and Cost Effective , ... Laguna Niguel, California (PRWEB) October 29, ... to heat treating of wrapped balloons on balloon catheters . Heat treating can ...
... Tenn., Nov. 2 TeamHealth Inc.,s parent company, Team Finance ... of 2009. , Net revenue less provision for ... increased 8.6% to $363.0 million from $334.3 million in the ... for the quarter increased 7.5% to $331.0 million from $307.9 ...
... with non-small cell lung cancer treated with preventative brain ... their risk of developing brain metastases (cancer spread in ... percent to 8 percent), compared to those who did ... presented at the plenary session November 2, 2009, at ...
... found, however, for most commonly used infection-fighters, , MONDAY, ... does not raise the risk for most birth defects, ... , Penicillin, which is the most commonly used antibiotic ... quinolones, other widely prescribed antibiotics, were not associated with ...
... Nov. 2 Accelify announced today that Indian Prairie School ... claiming services. Indian Prairie School District serves 28,825 students ... of Illinois. , "We are privileged to have the ... outstanding administrative team," said Alex Brecher, COO of Accelify. "It ...
... - Early-stage breast cancer patients with HER2 positive tumors one ... their disease, compared to those with early-stage disease who do ... by researchers at The University of Texas M. D. Anderson ... Journal of Clinical Oncology , is the first large ...
Cached Medicine News:Health News:Interface new Balloon Catheter Solutions PTA and PTCA Catheters 2Health News:Team Finance LLC Announces Third Quarter 2009 Results 2Health News:Team Finance LLC Announces Third Quarter 2009 Results 3Health News:Team Finance LLC Announces Third Quarter 2009 Results 4Health News:Team Finance LLC Announces Third Quarter 2009 Results 5Health News:Team Finance LLC Announces Third Quarter 2009 Results 6Health News:Team Finance LLC Announces Third Quarter 2009 Results 7Health News:Team Finance LLC Announces Third Quarter 2009 Results 8Health News:Team Finance LLC Announces Third Quarter 2009 Results 9Health News:What are the Real Benefits Versus Risks of Preventative Brain Radiation for Patients With Non-Small Cell Lung Cancer? 2Health News:What are the Real Benefits Versus Risks of Preventative Brain Radiation for Patients With Non-Small Cell Lung Cancer? 3Health News:CDC Study Links 2 Antibiotics to Birth Defects 2Health News:CDC Study Links 2 Antibiotics to Birth Defects 3Health News:CDC Study Links 2 Antibiotics to Birth Defects 4Health News:Indian Prairie School District Awards Contract to Accelify 2Health News:Early-stage, HER2-positive breast cancer patients at increased risk of recurrence 2Health News:Early-stage, HER2-positive breast cancer patients at increased risk of recurrence 3
... ideal for the physician who wishes to ... base of clinical applications. The innovative cooled ... the treaent of deeper lying veins. The ... vascular and pigmented lesions, including IPL Skin ...
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
Icefire has ice crystals on the top of a cool blue iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Medicine Products: